Classement en actions
#33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Prix de l'action
$0.5099
Dernière synchronisation: 2024-10-15
Capitalisation boursière
$7.60M
Changement (1 jour)
2.02%
Échange Anew Medical, Inc. (WENA)
Le prix WENA avec la capitalisation boursière de B
Capitalisation boursière de Anew Medical, Inc.(WENA)
Capitalisation boursière: $7.60M
En August 2026, Anew Medical, Inc. a une capitalisation boursière de $7.60M. Cela fait de Anew Medical, Inc. la 33455th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Anew Medical, Inc. du 2024 au 2026
WENA par rapport au top 5 des plus populaires stocks
| Prix pour WENA |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.452T
|
+71,731,742.10%
|
|
|
|
|
$4.490T
|
+59,076,428.18%
|
|
|
|
|
$4.162T
|
+54,765,924.71%
|
|
|
|
|
$3.676T
|
+48,370,628.76%
|
|
|
|
|
$2.833T
|
+37,275,082.79%
|
